MRNA vs WEAV · rev $145.0M vs rev $133.0M
Moderna Inc (MRNA) versus Weave Communications Inc (WEAV) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Weave Communications Inc (WEAV) is a health information services company listed on NYSE.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported WEAV revenue for 2026-06-30 was $133.0M. Net income was -$10.0M. WEAV currently screens at market cap $440.0M.
MRNA currently screens at market cap $24.52B. WEAV currently screens at market cap $440.0M.
Not investment advice. Open the MRNA and WEAV stock pages for the full models.
Not investment advice.